CANONICAL MONOGRAPH [7.20] • ID: TIP-MED-000122

1. Morphine Sulfate & Fentanyl (NDPS High-Alert Opioid Analgesics)

2. Pharmacological Class: Pure Mu-Opioid Receptor Agonists — Narcotic Analgesics (NDPS Act 1985 / Essential Narcotic Drugs [END] | HIGH-ALERT) • 3. Therapeutic Category: Pain, Inflammation, Rheumatology & Gout Medicines (Ch 07)

⚖️ Compare Medicine

4. Clinical Overview & Verified Formulation Identity

Generic Name & Identifier:
Morphine Sulfate & Fentanyl (NDPS High-Alert Opioid Analgesics)
Code: [7.20] | Stable ID: TIP-MED-000122

Verified Indian Market Brands / Status:
Representative Indian Market Examples (Edition 2.7 Ch 07 [7.20], p. 88): Morphine: Morphitroy (Troikaa), Morcontin Continus (Modi Mundipharma), Vermor. Fentanyl: Durogesic Transdermal Patch (J&J), Fenstud, Trofentyl (IV) — Strengths & Dosage Forms: Morphine IR Tablets: 10 mg, 20 mg; SR/CR Tablets: 10 mg, 30 mg, 60 mg; Oral Solution: 10 mg/5mL; IV/SC Injection: 10 mg/mL. Fentanyl Transdermal Patch (72-Hour): 12 mcg/h, 25 mcg/h, 50 mcg/h; IV: 50 mcg/mL

9. Dosage Forms & Strengths:
Morphine IR Tablets: 10 mg, 20 mg; SR/CR Tablets: 10 mg, 30 mg, 60 mg; Oral Solution: 10 mg/5mL; IV/SC Injection: 10 mg/mL. Fentanyl Transdermal Patch (72-Hour): 12 mcg/h, 25 mcg/h, 50 mcg/h; IV: 50 mcg/mL; Morphine IR Tablets: 10 mg, 20 mg; SR/CR Tablets: 10 mg, 30 mg, 60 mg; Oral Solution: 10 mg/5mL; IV/SC Injection: 10 mg/mL. Fentanyl Transdermal Patch (72-Hour): 12 mcg/h, 25 mcg/h, 50 mcg/h; IV: 50 mcg/mL
Route: Oral / Parenteral / Topical as specified by formulation

Indian Regulatory Schedule & NLEM Status:
Schedule H1 / Schedule X & NDPS Act 1985 Psychotropic/Narcotic Prescription Drug (Strict Statutory Register)
True

5 & 6. Mechanism of Action & Pharmacodynamics

Pure Mu-Opioid Receptor Agonists — Narcotic Analgesics (NDPS Act 1985 / Essential Narcotic Drugs [END] | HIGH-ALERT) acting on target receptor/enzyme pathways in Pain, Inflammation, Rheumatology & Gout Medicines (Ch 07): clinical efficacy is mediated via Pure Mu-Opioid Receptor Agonists — Narcotic Analgesics (NDPS Act 1985 / Essential Narcotic Drugs [END] | HIGH-ALERT) for Moderate-to-severe cancer pain (WHO Step 3 Palliative Care Ladder), acute myocardial infarction / cardiogenic pulmonary oedema pain, severe postoperative/trauma pain (Fentanyl is preferred over Morphine in severe CKD Stage 4–5!).

8. Therapeutic Indications

Moderate-to-severe cancer pain (WHO Step 3 Palliative Care Ladder), acute myocardial infarction / cardiogenic pulmonary oedema pain, severe postoperative/trauma pain (Fentanyl is preferred over Morphine in severe CKD Stage 4–5!)

10. Dosage and Administration (Educational Reference Summary)

Dosing & Clinical Context: Morphine Oral (Opioid-Naive Cancer Pain): Start 5–10 mg IR PO q4h (plus 5 mg PRN breakthrough); once daily requirement is stable, convert to 12-hourly SR Morphine (half total 24h dose BD). Fentanyl Patch (ONLY in Opioid-Tolerant Patients taking >=60 mg/day oral Morphine equivalent!): Apply 1 patch to flat non-hairy upper torso/arm and replace every 72 hours
Administration & Timing: Swallow Morphine SR/CR tablets whole; ALWAYS co-prescribe a stimulant + osmotic laxative (Bisacodyl/Senna + Lactulose/PEG) from Day 1 (tolerance NEVER develops to opioid constipation!) | Morphine IR: Every 4 hours around the clock. Morphine SR: Every 12 hours. Fentanyl Patch: Every 72 hours

11 & 13. Contraindications, Precautions and Warnings

🚫 11. Contraindications:

NDPS ACT 1985 / ESSENTIAL NARCOTIC DRUGS (END) STATUTORY GOVERNANCE: Requires NDPS license/register, double-lock custody, and shift-to-shift balance! Contraindicated in respiratory depression, acute bronchial asthma, paralytic ileus, raised intracranial pressure/head injury. Fentanyl Patch is CONTRAINDICATED in opioid-naive patients or acute postoperative pain!

⚠️ 13. Precautions and Warnings:

Renal: AVOID Morphine if eGFR <30 mL/min (active M6G/M3G metabolites cause prolonged coma & myoclonus — use Fentanyl or Buprenorphine in severe CKD/dialysis!). Hepatic: Reduce dose and extend interval by 50% in cirrhosis

7, 12, 14–18. Detailed Pharmacokinetics, Interactions, Special Populations & Counselling

7 & 16. Pharmacokinetics (ADME) & Renal / Hepatic Considerations

7. Pharmacokinetics (Absorption, Distribution, Metabolism, Excretion): Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.

16a. Renal Considerations: Renal: AVOID Morphine if eGFR <30 mL/min (active M6G/M3G metabolites cause prolonged coma & myoclonus — use Fentanyl or Buprenorphine in severe CKD/dialysis!). Hepatic: Reduce dose and extend interval by 50% in cirrhosis

16b. Hepatic Considerations: Renal: AVOID Morphine if eGFR <30 mL/min (active M6G/M3G metabolites cause prolonged coma & myoclonus — use Fentanyl or Buprenorphine in severe CKD/dialysis!). Hepatic: Reduce dose and extend interval by 50% in cirrhosis

12 & 14. Adverse Effects & Drug Interactions

12. Adverse Effects:

Constipation (near 100% without prophylactic laxatives!), nausea/vomiting (during first 5–7 days), drowsiness, miosis, pruritus, urinary retention
Life-threatening respiratory depression (RR <8–10/min, pinpoint pupils, coma -> reverse STAT with Naloxone 0.04–0.4 mg IV titrated!), neuroexcitatory myoclonus/delirium in CKD (from M6G/M3G accumulation!), fatal Fentanyl overdose if patch is cut or exposed to heat/fever/hot-water bottle!

14. Drug Interactions:

Benzodiazepines, Zolpidem, Gabapentinoids, Alcohol, and Antihistamines cause synergistic fatal respiratory depression; CYP3A4 inhibitors (Clarithromycin, Itraconazole, Fluconazole, Diltiazem) markedly increase Fentanyl levels!

15, 17 & 18. Special Populations, Clinical Monitoring & Patient Counselling

15. Use in Special Populations (Pregnancy, Lactation, Paediatrics, Geriatrics): Evaluate maternal-foetal benefit-risk ratio, paediatric mg/kg ceiling, and geriatric renal function prior to prescribing.

17. Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.

18. Patient Counselling & Storage:

Patient Counselling Checklist: CRITICAL FENTANYL PATCH RULES: (1) Remove old patch before applying new patch every 72 hours; (2) NEVER cut a patch; (3) NEVER apply a heating pad/hot-water bottle over a patch or sit in hot water (heat increases Fentanyl absorption 3-fold and causes fatal overdose!); take your prescribed laxative daily with Morphine
Meal & Clock Timing Instruction: Swallow Morphine SR/CR tablets whole; ALWAYS co-prescribe a stimulant + osmotic laxative (Bisacodyl/Senna + Lactulose/PEG) from Day 1 (tolerance NEVER develops to opioid constipation!) (Morphine IR: Every 4 hours around the clock. Morphine SR: Every 12 hours. Fentanyl Patch: Every 72 hours)
Missed Dose Protocol: Take scheduled cancer-pain doses by the clock (do not wait for severe pain to return)
Geriatric Dispensing Pearl: Start Morphine at 2.5–5 mg IR q4–6h in frail elderly; avoid Morphine if CrCl <30 mL/min

Storage & Dispensing Notes: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Morphine IR Tablets: 10 mg, 20 mg; SR/CR Tablets: 10 mg, 30 mg, 60 mg; Oral Solution: 10 mg/5mL; IV/SC Injection: 10 mg/mL. Fentanyl Transdermal Patch (72-Hour): 12 mcg/h, 25 mcg/h, 50 mcg/h; IV: 50 mcg/mL

Visual Pharmacology Illustration (PLATE-8.1)

Figure 8.1: The 12-step physiological journey of a typical orally administered solid dosage form through Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME). Note: Parenteral (IV), sublingual, and inhalational routes bypass gastrointestinal absorption and/or hepatic first-pass metabolism.

19. Authoritative References & Source Traceability

Primary Reference Record: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 07 [7.20] (p. 88)

Verification Portals: Indian Pharmacopoeia Commission (IPC) • CDSCO (India Jurisdiction) • NCBI Bookshelf • DailyMed (US FDA Label Reference)

Last Reviewed Date: 2026-11-08 • Related Study Guide: Clinical Pharmacokinetics: ADME, Vd, Clearance & Half-Life →

← Back to All 519 Medicine Monographs 📖 Read Related Clinical Guide → ⚠️ Report Error